Acumen Pharmaceuticals Q3 EPS $(0.35) Beats $(0.37) Estimate

Benzinga · 2d ago
Acumen Pharmaceuticals (NASDAQ:ABOS) reported quarterly losses of $(0.35) per share which beat the analyst consensus estimate of $(0.37) by 5.41 percent. This is a 20.45 percent increase over losses of $(0.44) per share from the same period last year.